In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 26th, 2005 | 26 | Yes |
Popular Name: Levofloxacin Levofloxacin
Find On: PubMed — Wikipedia — Google
CAS Numbers: 100986-54-4 , 100986-85-4 , 118120-51-7 , 138199-71-0 , 1400645-02-4 , 177325-13-2 , 226578-51-4 , 82419-36-1 , 83380-47-6 , [100986-85-4] , [118120-51-7] , [138199-71-0] , [177325-13-2] , [226578-51-4] , [82419-36-1]
100986-85-4; C07660; Levofloxacin; Ofloxacin S-(-)-form
118120-51-7; D08291; Ofloxacin hydrochloride; Tarivid (TN)
CPD000058192; OFLOXACIN; SAM002264629
DL-8280, HOE-280, Exocin, Flobacin, Floxin, Floxil, Monoflocet
DR-3355: L-isomer of ofloxacin
Floxin;Levofloxacin;Levofloxacin hydrate;Ofloxacin;Quixin
LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Levofloxacin hemihydrate, 98.5%+
Levofloxacin hemihydrate, Antibiotic for Culture Media Use Only
Levofloxacin tablet, suspension or intravenous
Levofloxacin, Antibiotic for Culture Media Use Only
Ofloxacin hydrochloride, 98.5%+
Ofloxacin hydrochloride, Antibiotic for Culture Media Use Only
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | -0.26 | 9.75 | -92.26 | 1 | 7 | 0 | 79 | 361.373 | 2 | ↓ |
Mid Mid (pH 6-8) | -3.01 | 7.88 | -73.44 | 2 | 7 | 1 | 82 | 362.381 | 1 | ↓ |
Mid Mid (pH 6-8) | -0.26 | 7.41 | -63.01 | 0 | 7 | -1 | 78 | 360.365 | 2 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Molecular_Solubility | 1.607 | Bitter DB |
mechanism | . | ZereneX Building Blocks |
ALOGPS_SOLUBILITY | 1.44e+00 g/l | DrugBank-approved |
MP | 224 | TCI |
Purity | 97% | APIChem |
therap | antibacterial | MicroSource Spectrum |
biological_use | Antibacterial agent | IBScreen Bioactives IBScreen Bioactives |
biological_use | Antibacterial agent; Antiseptic | ZereneX Building Blocks |
Therapy | antibiotic | SMDC Iconix |
Therapy | antimicrobial | SMDC Pharmakon |
biological_use | Antiseptic | IBScreen Bioactives |
UniProt Database Links | CBRA_ECOLI; MQSR_ECOLI; Y1258_MYCTU; Y2477_MYCTU | ChEBI |
mechanism | DNA gyrase inhibitor | IBScreen Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : O-801 | NIH Clinical Collection via PubChem |
UniProt Database Links | PARC_STRPN; PARE_STRPN | ChEBI |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: O-801 | NIH Clinical Collection via PubChem |
biological_use | Shows broad spectrum of activity against gram-positive and -negative bacteria | IBScreen Bioactives |
Target | Topoisomerase | Selleck Chemicals |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
KCNH2-1-E | HERG (cluster #1 Of 5), Eukaryotic | Eukaryotes | 2850 | 0.30 | Binding ≤ 10μM |
KCNH2-1-E | HERG (cluster #1 Of 5), Eukaryotic | Eukaryotes | 3040 | 0.30 | Binding ≤ 10μM |
C3SLN2-1-B | DNA Gyrase Subunit B (cluster #1 Of 1), Bacterial | Bacteria | 1500 | 0.31 | Binding ≤ 10μM |
Q47245-1-B | DNA Gyrase Subunit A (cluster #1 Of 1), Bacterial | Bacteria | 1500 | 0.31 | Binding ≤ 10μM |
Z50380-2-O | Mycobacterium Smegmatis (cluster #2 Of 4), Other | Other | 3130 | 0.30 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
Q47245_ECOLX | Q47245 | DNA Gyrase Subunit A, Ecolx | 1500 | 0.31 | Binding ≤ 10μM |
C3SLN2_ECOLX | C3SLN2 | DNA Gyrase Subunit B, Ecolx | 1500 | 0.31 | Binding ≤ 10μM |
KCNH2_HUMAN | Q12809 | HERG, Human | 3040 | 0.30 | Binding ≤ 10μM |
Z50380 | Z50380 | Mycobacterium Smegmatis | 1730 | 0.31 | Functional ≤ 10μM |
Description | Species |
---|---|
Voltage gated Potassium channels |